LAURANTIS PHARMA
Laurantis Pharma Oy is a specialty pharmaceutical development company with a broad, clinical-stage portfolio in three therapeutic areas: dermatology, ophthalmology, and oncology. Using two proprietary technologies, Laurantis is developing first-in-class products for commercially and medically significant niche indications in these areas. Laurantis was formed in December 2010 through a merger of the Finnish drug development companies Oy Lx Therapies Ltd and BioCis Pharma Oy.
LAURANTIS PHARMA
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2003-01-01
Address:
Turku, Western Finland, Finland
Country:
Finland
Website Url:
http://www.laurantis.com
Total Employee:
1+
Status:
Active
Contact:
358 2478 8378
Email Addresses:
[email protected]
Total Funding:
5.64 M EUR
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 Hetzner Sendgrid
Similar Organizations
Exponential Biotherapies
Exponential Biotherapies develops therapeutics to attenuate overreactions of the immune system.
Khonsu Therapeutics
Developing therapeutic proteins for autoimmune & inflammatory indications in human & animal health
Current Advisors List
Current Employees Featured
Founder
Investors List
Inveni Capital
Inveni Capital investment in Venture Round - Laurantis Pharma
Broadview Ventures
Broadview Ventures investment in Venture Round - Laurantis Pharma
